FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3087756603> ?p ?o ?g. }

• W3087756603 endingPage "571" @default.
• W3087756603 startingPage "563" @default.
• W3087756603 abstract "Optimal treatment for older adults with stage III non-small cell lung cancer (NSCLC) remains unclear. Here we hypothesized that sequential chemoradiation therapy (sCRT) is better tolerated than concurrent (cCRT) but confers acceptable efficacy. We evaluated these strategies in older adults utilizing Alliance for Clinical Trials in Oncology data.Pooled analyses from 6 first-line stage III NSCLC CRT trials (Cancer and Leukemia Group B 8433, 8831, 9130, 30106, 30407, 39801) were used to compare toxicity and survival outcomes with cCRT versus sCRT in patients age ≥ 65 years. Grade 3-5 adverse events (AEs), progression-free and overall survival (PFS; OS) are reported with adjustment for covariates.Four hundred older adults, of whom 106 (26.5%) had received sCRT and 294 (73.5%) had received cCRT, comprised the cohorts. Virtually all had an Eastern Cooperative Oncology Group performance status (ECOG PS) 0-1 (99%). More grade 3-5 AEs were observed at any time-point with cCRT than sCRT (94.2% versus 86.8%; 95% confidence interval for difference in proportions, 1.3%, 15.5%) and this finding remained after adjusting for length of study treatment (P = 0.018). Comparable PFS and OS were observed with sCRT versus cCRT (median: 8.0 versus 9.2 months; median: 11.9 versus 13.4 months, respectively) even after adjustment for age, sex, ECOG PS, body mass index, pretreatment weight loss, stage, and cisplatin-based therapy (P = 0.604 and P = 0.906, respectively).These data show that sCRT was associated with less toxicity than cCRT with no associated statistically significant decrease in efficacy outcomes and that sCRT merits further study in this population." @default.
• W3087756603 created "2020-09-25" @default.
• W3087756603 creator A5016840607 @default.
• W3087756603 creator A5023960433 @default.
• W3087756603 creator A5030634220 @default.
• W3087756603 creator A5031116230 @default.
• W3087756603 creator A5043692152 @default.
• W3087756603 creator A5059012052 @default.
• W3087756603 creator A5070958912 @default.
• W3087756603 creator A5072978110 @default.
• W3087756603 creator A5075372434 @default.
• W3087756603 creator A5077959964 @default.
• W3087756603 creator A5088803460 @default.
• W3087756603 date "2021-05-01" @default.
• W3087756603 modified "2023-09-27" @default.
• W3087756603 title "Toxicity and survival outcomes in older adults receiving concurrent or sequential chemoradiation for stage III non-small cell lung cancer in Alliance trials (Alliance A151812)" @default.
• W3087756603 cites W1481275904 @default.
• W3087756603 cites W1944220675 @default.
• W3087756603 cites W1987827337 @default.
• W3087756603 cites W1991020867 @default.
• W3087756603 cites W1995805135 @default.
• W3087756603 cites W2004784900 @default.
• W3087756603 cites W2029241191 @default.
• W3087756603 cites W2046970652 @default.
• W3087756603 cites W2062581935 @default.
• W3087756603 cites W2082687472 @default.
• W3087756603 cites W2098835005 @default.
• W3087756603 cites W2102361674 @default.
• W3087756603 cites W2104701073 @default.
• W3087756603 cites W2110469369 @default.
• W3087756603 cites W2112672701 @default.
• W3087756603 cites W2121138562 @default.
• W3087756603 cites W2132907028 @default.
• W3087756603 cites W2152939220 @default.
• W3087756603 cites W2153294383 @default.
• W3087756603 cites W2159997815 @default.
• W3087756603 cites W2170768661 @default.
• W3087756603 cites W2178570731 @default.
• W3087756603 cites W2317448174 @default.
• W3087756603 cites W2516607279 @default.
• W3087756603 cites W2528393079 @default.
• W3087756603 cites W2567412772 @default.
• W3087756603 cites W2612390378 @default.
• W3087756603 cites W2753065806 @default.
• W3087756603 cites W2778066199 @default.
• W3087756603 cites W2782712321 @default.
• W3087756603 cites W2786721201 @default.
• W3087756603 cites W2809051383 @default.
• W3087756603 cites W2826220405 @default.
• W3087756603 cites W2893824814 @default.
• W3087756603 cites W2992931937 @default.
• W3087756603 cites W3147894994 @default.
• W3087756603 cites W4293241248 @default.
• W3087756603 doi "https://doi.org/10.1016/j.jgo.2020.09.005" @default.
• W3087756603 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7960567" @default.
• W3087756603 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32950428" @default.
• W3087756603 hasPublicationYear "2021" @default.
• W3087756603 type Work @default.
• W3087756603 sameAs 3087756603 @default.
• W3087756603 citedByCount "5" @default.
• W3087756603 countsByYear W30877566032020 @default.
• W3087756603 countsByYear W30877566032021 @default.
• W3087756603 countsByYear W30877566032022 @default.
• W3087756603 countsByYear W30877566032023 @default.
• W3087756603 crossrefType "journal-article" @default.
• W3087756603 hasAuthorship W3087756603A5016840607 @default.
• W3087756603 hasAuthorship W3087756603A5023960433 @default.
• W3087756603 hasAuthorship W3087756603A5030634220 @default.
• W3087756603 hasAuthorship W3087756603A5031116230 @default.
• W3087756603 hasAuthorship W3087756603A5043692152 @default.
• W3087756603 hasAuthorship W3087756603A5059012052 @default.
• W3087756603 hasAuthorship W3087756603A5070958912 @default.
• W3087756603 hasAuthorship W3087756603A5072978110 @default.
• W3087756603 hasAuthorship W3087756603A5075372434 @default.
• W3087756603 hasAuthorship W3087756603A5077959964 @default.
• W3087756603 hasAuthorship W3087756603A5088803460 @default.
• W3087756603 hasBestOaLocation W30877566032 @default.
• W3087756603 hasConcept C121608353 @default.
• W3087756603 hasConcept C126322002 @default.
• W3087756603 hasConcept C141071460 @default.
• W3087756603 hasConcept C143998085 @default.
• W3087756603 hasConcept C146357865 @default.
• W3087756603 hasConcept C151730666 @default.
• W3087756603 hasConcept C197934379 @default.
• W3087756603 hasConcept C2776256026 @default.
• W3087756603 hasConcept C29730261 @default.
• W3087756603 hasConcept C44249647 @default.
• W3087756603 hasConcept C509974204 @default.
• W3087756603 hasConcept C71924100 @default.
• W3087756603 hasConcept C86803240 @default.
• W3087756603 hasConceptScore W3087756603C121608353 @default.
• W3087756603 hasConceptScore W3087756603C126322002 @default.
• W3087756603 hasConceptScore W3087756603C141071460 @default.
• W3087756603 hasConceptScore W3087756603C143998085 @default.
• W3087756603 hasConceptScore W3087756603C146357865 @default.
• W3087756603 hasConceptScore W3087756603C151730666 @default.
• W3087756603 hasConceptScore W3087756603C197934379 @default.
• W3087756603 hasConceptScore W3087756603C2776256026 @default.

• next